VAN HEUVELEN STRATEGIES, LLC for ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 21, 2014 | $40,000 | Replaced |
| 2nd Quarter - Amendment | Oct 14, 2014 | $50,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Prescription drug user fee act and other issues related to generic drugs; H.R. 3204 - The Drug Quality and Security Act, S. 1720 - Patent Transparency and Improvements Act of 2013, H.R. 3309 - Innovation Act, S. 2049 - Transparency in Assertion of Patents Act, S. 1013 - Patent Abuse Reduction Act, S. 1612 - Patent litigation and Integrity Act, H.R. 325 - Continuing Resolution, S. Con. Res. 8, FY 2014 Budget Resolution.on and Integrity Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD | Chief of Staff to Senator Jeff Bingaman |
Budget/Appropriations BUD
Prescription drug user fee act and other issues related to generic drugs; H.R. 3204 - The Drug Quality and Security Act, S. 1720 - Patent Transparency and Improvements Act of 2013, H.R. 3309 - Innovation Act, S. 2049 - Transparency in Assertion of Patents Act, S. 1013 - Patent Abuse Reduction Act, S. 1612 - Patent litigation and Integrity Act, H.R. 325 - Continuing Resolution, S. Con. Res. 8, FY 2014 Budget Resolution.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD | Chief of Staff to Senator Jeff Bingaman |
Labor Issues/Antitrust/Workplace LBR
Prescription drug user fee act and other issues related to generic drugs; H.R. 3204 - The Drug Quality and Security Act, S. 1720 - Patent Transparency and Improvements Act of 2013, H.R. 3309 - Innovation Act, S. 2049 - Transparency in Assertion of Patents Act, S. 1013 - Patent Abuse Reduction Act, S. 1612 - Patent litigation and Integrity Act, H.R. 325 - Continuing Resolution, S. Con. Res. 8, FY 2014 Budget Resolution.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT VAN HEUVELEN | Chief of Staff to Senator Kent Conrad |
| STEPHEN DOUGLAS WARD | Chief of Staff to Senator Jeff Bingaman |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.